⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1776065 | 0.96 | — | — | |
| SCHEMBL18286851 | 0.78 | — | — | |
| SCHEMBL24939564 | 0.75 | — | — | |
| SCHEMBL24871 | 0.73 | — | — | |
| SCHEMBL1269508 | 0.73 | — | — | |
| SCHEMBL4247378 | 0.73 | — | — | |
| SCHEMBL1172952 | 0.73 | — | — | |
| SCHEMBL8917932 | 0.73 | — | — | |
| SCHEMBL10151244 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL20969298 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240322244-A1 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2024-09-26 | — | — | US | claimed |
| WO-2024196936-A2 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| CN-113876967-B | Preparation method of alternating fluorine-containing polymer fluorine magnetic resonance imaging probe | 北京化工大学 | 2023-02-28 | — | — | CN | claimed |
| CN-113876967-A | Preparation method of alternating fluorine-containing polymer fluorine magnetic resonance imaging probe | 北京化工大学 | 2022-01-04 | — | — | CN | claimed |
| CN-113164471-A | A composition for treating amyloid cranial nerve disease and its treatment method | 淀粉样蛋白解决方案株式会社 | 2021-07-23 | — | — | CN | claimed |
| CN-111333502-A | Method for separating perfluorodiacyl fluoride isomer | 中蓝晨光化工研究设计院有限公司 | 2020-06-26 | — | — | CN | claimed |
| CN-108123175-B | Synthesis method of amide compound, amide compound and non-aqueous electrolyte | 微宏动力系统（湖州）有限公司 | 2020-05-22 | — | — | CN | claimed |
| US-8143408-B2 | N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | ASTRAZENECA AB (SE) | 2012-03-27 | — | — | US | claimed |
| US-20100137322-A1 | NOVEL N-(8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N-(5-HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2010-06-03 | — | — | US | claimed |
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | claimed |
| EP-0639067-A4 | METHOD FOR HYPERTHERMIC POTENTIATION OF TISSUE. | UNGER EVAN C (US) | 1995-04-19 | — | — | EP | claimed |
| EP-0639067-A1 | METHOD FOR HYPERTHERMIC POTENTIATION OF TISSUE | UNGER, Evan C (US) | 1995-02-22 | — | — | EP | claimed |
| WO-1993021889-A1 | METHOD FOR HYPERTHERMIC POTENTIATION OF TISSUE | UNGER EVAN C (US) | 1993-11-11 | — | — | WO | claimed |
| US-5149319-A | Methods for providing localized therapeutic heat to biological tissues and fluids | CEREVAST THERAPEUTICS, INC. | 1992-09-22 | — | — | US | claimed |
| US-12629341-B2 | Functional derivatives of maleimide copolymers for nanodisc production | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2026-05-19 | — | — | US | disclosed |
| US-20240322244-A1 | LOCALIZED HIGH CONCENTRATION ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING THE SAME | SILA NANOTECHNOLOGIES, INC. | 2024-09-26 | — | — | US | disclosed |
| US-5401851-A | Preparation of proline derivatives | ELI LILLY AND COMPANY (US) | 1995-03-28 | — | — | US | disclosed |
| EP-0573271-A1 | Angiotensin II antagonists | ELI LILLY AND COMPANY (US) | 1993-12-08 | — | — | EP | disclosed |
| US-3960949-A | DIABETES | SCHERING AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |